Neurogenic factors and hypertension in chronic renal failure

Journal of Nephrology

Volumn 10, Issue 4, 1997, Pages 184-187

  Campese, Vito M ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

Chronic renal failure; Hypertension; Renal nerves; Sympathetic nervous system

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PRESSURE MONITORING; CONFERENCE PAPER; DISEASE SEVERITY; HYPERTENSION; HYPOTHALAMUS; KIDNEY DENERVATION; KIDNEY FAILURE; LOCUS CERULEUS; NEPHRECTOMY; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RHIZOTOMY; SODIUM RETENTION; VASOCONSTRICTION;

ANIMALS; HYPERTENSION; HYPOTHALAMUS, POSTERIOR; KIDNEY FAILURE, CHRONIC; LOCUS COERULEUS; NEPHRECTOMY; NOREPINEPHRINE; RATS; RHIZOTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 0030844734     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Curtis JR, Eastwood JB, Smith EKM, et al. Maintenance hemodialysis. Q J Med 1969; 38: 49-89.
2. Schupak E, Sullivan JE, Lee DV. Chronic hemodialysis in unselected patients. Annals of Internal Med 1967; 67: 708-17.
3. Klooker P, Bommer J, Ritz E. Treatment of hypertension in dialysis patients. Blood Purif 1985; 3: 15-26.
4. Baumgart P, Walger P, Gemen S, et al. Blood pressure deration in the night in chronic renal failure, hemodialysis and renal transplantation. Nephron 1991; 57: 293-8.
5. Gosse P, Campello G, Roudat T, et al. High night blood pressure in treated hypertensive patients: not harmless. Am J Hypertens 1988; 1: S195-8.
6. Coleman TG, Guyton AC. Hypertension caused by salt loading in the dog: III. Onset transients of cardiac output and other variables. Circ Res 1969; 25: 153-60.
7. Weidman P. Pathogenesis of hypertension associated with chronic renal failure. Contr Nephrol 1984; 41: 47-65.
8. De Wardener HE, Mac Gregor GA. Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: it's possible role in essential hypertension. Kidney Int 1980; 18: 1-9.
9. +ATPase activity. J Hypertension 1988; 6 (Suppl 14): S363-5.
10. Tobian L Jr, Binion JT. Tissue cations and water in arterial hypertension. Circulation 1952; 5: 754-8.
11. Dathan JRE, Johnson DM, Goodwin FJ. The relationship between fluid compartment volumes, renal activity and blood pressure in chronic renal failure; Clin Science Mol Med 1973; 45: 77-78.
12. Dorhout Mees EJ. Renin and blood volume in chronic renal failure: a comparison with essential hypertension. Nephron 1987; 45: 7-15.
13. Schultze G, Prefke S, Malzahn M. Blood pressure in terminal renal failure. Fluid spaces and renin-angiotensin system. Nephron 1980; 25: 15-24.
14. Schalekamp MADH, Schalekamp-Kuyken MPA, deMoor-Fruytier M. Interrelationships between blood pressure, renin, renin substrate and blood volume in terminal renal failure. Clin Sci Mol Med 1973; 45: 417-28.
15. Lazarus JM, Hampers CL, Merrill JP. Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy. Arch Intern Med 1974; 133: 1059-66.
16. Campese VM. Autonomic nervous system dysfunction in uraemia; Neph Dial Tran 1990; (Suppl 1): 98-101.
17. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG. Mechanisms of autonomie nervous system dysfunction in uremia. Kidney Int 1981; 20: 246-53.
18. Atuk NO, Bailey CJ, Turner S, Peach MJ, Westervelt FB, Jr. Red blood cell catechol-o-methyl transferase, plasma catecholamines and renin in renal failure. Trans Am Soc Artif Intern Organs 1976; 22: 195-200.
19. Lake CR, Ziegler MG, Coleman MD, Kopin IJ. Plasma levels of norepinephrine and dopamine-beta-hydroxylase in CRF patients treated with dialysis. Cardiovasc Med 1979; 1: 1099-111.
20. Henrich WL, Katz FH, Molinoff PB, Schrier RW. Competitive effects of hypokalemia and volume depletion on plasma renin activity, aldosterone and catecholaminc concentrations in hemodialy-sis patients. Kidney Int 1977; 12: 279-84.
21. Izzo JL, Izzo MS, Sterns RH, Freeman RB. Sympathetic nervous system hyperactivity in maintenance hemodialysis patients; Trans Am Soc Artif Organs 1982; 28: 604-7.
22. Cuche JI, Prinseau J, Selz F, Ruget G, et al. Plasma free sulfo and glucuroconjugated calecholamines in uremic patients. Kidney Int 1986; 30: 566-72.
23. Smorgorzewski M, Campese VM, Massry SG. Abnormal norepinephrine uptake and release in brain synaptosomes in chronic renal failure. Kidney Int 1989; 36: 458-65.
24. Converse RL Jr, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with CRF. N Engl J Med 1992; 327: 1912-8.
25. Campese VM. Is hypertension in chronic renal failure neurogenic in nature? Editorial. Neph Dial Trap 1994; 9: 741-2.
26. Bigazzi R, Kogosov E, Campese VM. Altered norepinephrine turnover in the brain of rats with chronic renal failure. J Am Soc Nephrol 1994; 4: 1896-900.
27. Recordati G, Moss NG, Genovisi S, Rogenes P. Renal chemoreceptors. J Auton Nerv Syst 1981; 3: 237-51.
28. Katholi RE. Renal nerves and hypertension: an update. Fed Proc 1985; 44: 2846-50.
29. DiBona GF. The function of the renal nerves. Rev Physiol Biochem Pharmacol 1982; 94: 75-181.
30. Faber JE, Brody MJ. Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat. Circ Res 1985; 57: 676-88.
31. Calaresu FR, Ciriello J. Renal afferent nerves affect discahrge rate of medullary and hypothalamic single units in cat. J Auton Nerv Syst 1981; 3: 311-20.
32. Ciriello J, Calaresu FR. Central projection of afferent renal fibers in the rat: an anterograde transport study of horeradish peroxidase. J Auton Nerv Syst 1983; 8: 273-85.
33. Katholi RE, Whitlow PL, Hageman GR, Woods T. Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves. J Hypertension 1984; 2: 349-59.
34. Katholi RE, Winternitz SR, Oparil S. Decrease in peripheral sympathetic nervous system activity following renal denervation or unclipping in the one-kidney one-clip Goldblatt hypertensive rat. J Clin Invest 1982; 69: 55-62.
35. Shaohua YE, Burak Ozgur, Vito M. Campese. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 1997; 51: 722-7.
36. Wyss JM, Aboukarsh N, Oparil S; Sensory denervation of the kidney attenuates renovascular hypertension in the rat. Am J Physiol 1986; 19: H82-6.
37. Katholi RE, Naftilan AJ, Oparil S. Importance of renal sympathetic tone in the development of DOCA-salt hypertensionin rats. Hypertension 1980; 2: 266-73.
38. Katholi RE, Winternitz SR, Oparil S. Role of the renal nerves in the pathogenesis of one-kidney renal hypertension in the rat. Hypertension 1981; 3: 404-9.
39. Jing-Yun P, Bishop VS, Ball NA, Haywood JR. Inability of dorsal spinal rhizotomy to prevent wrap hypertension in rats. Hypertension 1985; 7: 722-8.
40. Wyss JM, Oparil S, Sripairojthikoon W. Neuronal control of the kidney: contribution to hypertension. Can J Physiol Pharmacol 1992; 70: 759-70.
41. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 1995; 25 [part 2]: 878-82.
42. Campese VM, Kogosov E, Koss M. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis 1995; 26: 861-5.